Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DPNB vs Tramadol for Catheter-related Bladder Discomfort
NCT01721031Phase 3Completed
- Sponsor
- West China Hospital of Sichuan University
- Start
- Apr 2013
- Primary completion
- Dec 2015
- Modality
- Targeted Liposomes, Stealth (PEGylated) Liposomes, Conventional Liposomes
- Countries
- 1
01
Overview
Phase 3, randomised, single-blind trial of ropivacaine hydrochloride liposomal suspension injection in cystitis, sponsored by West China Hospital of Sichuan University. Primary endpoint: Catheter-related bladder discomfort at 6 months. Started Apr 2013; status: completed.
02
Drugs
ropivacaine hydrochloride liposomal suspension injection
03
Conditions
cystitis
Beyond the preview
Go deeper on NCT01721031.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01721031.